The single market of the Eurasian Economic Union. Industry’s perspective

The Eighth annual Conference “State regulation and Russian pharmaceutical industry- 2016” will be held in Moscow on March 31. State representatives and business community will have a chance to discuss perspectives and opportunities of the mutual market within the Eurasian Economic Union.

The meeting is organized by the Association of the Russian Pharmaceutical Manufacturers (ARPM), the Association of International Pharmaceutical Manufacturers (AIPM), analytical company DSM Group, Scientific Institute of healthcare organization and medical management of the Health department of Moscow, and the Eurasian Economic Commission.

The conference will start for the session “New regulation of medicine circulation and its application within the EAEU market”. Participants of the session will discuss mechanisms of mutual recognition of medicine registration, legislative issues of the medical market integration processes, legislation of the parallel import, GMP audit, as well as advantages and disadvantages of allowance for foreign companies to participate in state trades. The session will be moderated by Director General of the ARPM, Victor Dmitriev and CEO of the AIPM, Vladimir Shipkov.

The conference will also have a session on good pharmacovigilance practices (GVP), moderated by Director if the Center of Educational Program FGBY of the Scientific Centre of Medical Use of the Health Ministry, Rosa Yagudina.

The conference traditionally brings together a lot of experts of the industry, including business and state officials. This year the conference will be attended by:

Member of the group of technical regulation of the EAEU, Valeriy Koreshov

Chairmen of the State Duma Committee in healthcare, Sergey Fugal

Deputy minister if Industry and Trade, Sergey Tcyb

Head of the Federal Pharmacovigilance service, Mikhail Murashko

Head of the Department on drug circulation of the Ministry of Health, Elena Maksimkina

Head of the department of control in healthcare of the Federal Antimonopoly Service, Timophey Nigegorodcev

First Deputy Director of the Institute of Legislation of the Government of Russia, Anatoliy Kapustin

Executive president of the RSPP, Victor Cherepov

Director General of the Center for expertise and quality control of medicine of the Health Ministry, Vitaly Omelyanovsky

Also, representatives of regulatory organs from the members of the EAEU were invited to participate. Among them:

Deputy Chairman of the Committee of control of medical and pharmaceutical activity of the Health Ministry of Kazakhstan, Larisa Pak

Head of the Department of pharmaceutical inspection and organization of medical provision of the Health Ministry of Belarus, Lyudmila Ruetskaya

First deputy director of the Department of medical provision of the Health Ministry of, Kirgizstan, Djanil Djusupova

“For over three years members of the working group and medical professionals were developing mutual approaches to regulation of circulation of medicines wishing the EAEU. Today, the rules of regulation are almost designed. They are based on world’s most successful good pharmacovigilance practices. However, our work is not finished yet. It only begins. We have to start the mechanisms of mutual recognition of drug registration, create the Pharmacopeia of the Union. We also have to work out the system of mutual inspectorate of production facilities, as well as many other important issues.

I am confident that the mutual system of regulation of will promotes affordability and accessibility if effective and safe medicines for people,” said Head of the department of Pharmaceutical inspectorate and organization of medical provision of the Health Ministry of Belarus, Lyudmila Reutskaya.


The conference will take place in hotel “Borodino” (yl. Rusakivskaya d. 13 str. 5), Moscow, on March 31, 2016. We invite all interested parties to participate.


For more information contact the Association of the Russian Pharmaceutical Manufacturers,

 7 (495) 231 42 53


Пресс-служба АРФП